Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer ; day:27 ; month:12 ; year:2016 ; pages:1-11
Advances in therapy ; (27.12.2016), 1-11
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Breul, Jürgen
- Beteiligte Personen und Organisationen
-
Lundström, Eija
Purcea, Daniela
Venetz, Werner P.
Cabri, Patrick
Dutailly, Pascale
Goldfischer, Evan R.
SpringerLink (Online service)
- DOI
-
10.1007/s12325-016-0466-7
- URN
-
urn:nbn:de:1111-201701253893
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Breul, Jürgen
- Lundström, Eija
- Purcea, Daniela
- Venetz, Werner P.
- Cabri, Patrick
- Dutailly, Pascale
- Goldfischer, Evan R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sustained-release drug delivery systems
Current Advances in Sustained Release Microneedles
Biorelevant im vitro drug-release testing of sustained-release parenterals
Development of sustained release formulations for phytopharmaceuticals
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer
Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants
Testosterone inhibits the growth of prostate cancer xenografts in nude mice
Biodegradable sponges from hydrocolloids as sustained release drug carrier systems
Sustained release of amoxicillin from hydroxyapatite nanocomposite for bone infections
Sustained-release drug delivery systems
Current Advances in Sustained Release Microneedles
Biorelevant im vitro drug-release testing of sustained-release parenterals
Development of sustained release formulations for phytopharmaceuticals
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer
Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants
Testosterone inhibits the growth of prostate cancer xenografts in nude mice
Biodegradable sponges from hydrocolloids as sustained release drug carrier systems
Sustained release of amoxicillin from hydroxyapatite nanocomposite for bone infections
Sustained-release drug delivery systems
Current Advances in Sustained Release Microneedles
Biorelevant im vitro drug-release testing of sustained-release parenterals
Development of sustained release formulations for phytopharmaceuticals
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer
Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants
Testosterone inhibits the growth of prostate cancer xenografts in nude mice
Biodegradable sponges from hydrocolloids as sustained release drug carrier systems